News from luminex corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 08, 2016, 08:30 ET Luminex Corporation Receives FDA Emergency Use Authorization for Zika Virus Molecular Detection Assay

 Luminex Corporation (NASDAQ: LMNX) today announced that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug...


Aug 03, 2016, 08:30 ET Luminex Corporation Receives FDA Clearance for New Molecular Test for Identification and Differentiation of Influenza A/B and Respiratory Syncytial Virus

 Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES® Flu A/B & RSV Assay. This...


Jul 28, 2016, 16:05 ET Luminex Corporation Reports Second Quarter 2016 Results

 Luminex Corporation (NASDAQ:LMNX) today announced financial results for the second quarter ended June 30, 2016.  Financial and operating...


Jul 20, 2016, 08:30 ET Luminex Corporation Second Quarter Earnings Release Scheduled for July 28; Revision to Conference Call Date/Time

Luminex Corporation (NASDAQ: LMNX) today announced that it will now hold a conference call to discuss the second quarter operating highlights and...


Jul 08, 2016, 08:30 ET Luminex Corporation Second Quarter Earnings Release Scheduled for July 28, 2016

 Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the second quarter ended June 30, 2016 on Thursday,...


Jul 06, 2016, 14:38 ET Luminex Corporation obtient l'autorisation de la FDA et le marquage CE-DIV pour son système ARIES M1

L'extension de la plateforme ARIES offre des avantages significatifs aux laboratoires cliniques présentant des exigences de débit...


Jul 06, 2016, 11:37 ET Luminex Corporation recibe aprobación FDA y marca CE-IVD para el sistema ARIES M1

La extensión de la plataforma ARIES proporciona los beneficios significativos de ARIES para laboratorios clínicos con menores...


Jul 06, 2016, 07:00 ET Luminex Corporation Receives FDA Clearance and CE-IVD Mark for the ARIES M1 System

 Luminex Corporation (NASDAQ: LMNX) today announced it has received FDA clearance and CE-IVD marking for a new in vitro diagnostic system, the...


Jul 06, 2016, 07:00 ET Luminex Corporation erhält die FDA-Zulassung und CE-IVD-Kennzeichnung für das ARIES M1 System

Die Erweiterung der ARIES-Plattform bietet die nennenswerten Vorteile von ARIES auch für klinische Labors mit geringeren...


Jun 30, 2016, 08:55 ET Luminex Corporation Completes Acquisition of Nanosphere, Inc.

 Luminex Corporation (NASDAQ: LMNX) today announced that Luminex has completed its previously announced acquisition of Nanosphere, Inc....


Jun 22, 2016, 16:05 ET Luminex Corporation To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference

 Luminex Corporation (NASDAQ: LMNX) today announced that management will present at Cantor Fitzgerald's 2nd Annual Healthcare Conference to be...


Jun 02, 2016, 06:00 ET Luminex Corporation Announces Commencement of Tender Offer for All Outstanding Shares of Nanosphere, Inc. Common Stock

 Luminex Corporation (NASDAQ: LMNX) announced today that its wholly-owned subsidiary Commodore Acquisition, Inc. has commenced its...


Jun 01, 2016, 13:48 ET Luminex Corporation obtient le marquage CE-IVD pour l'essai ARIES relatif au virus grippal A/B et au VRS

 Luminex Corporation (NASDAQ : LMNX) a annoncé aujourd'hui que la société avait obtenu le statut CE-IVD en vertu de la...


Jun 01, 2016, 09:15 ET Luminex Corporation recibe la Marca CE-IVD para el ensayo ARIES Flu A/B & RSV

 Luminex Corporation (NASDAQ: LMNX) anunció hoy que ha recibido la categoría CE-IVD según la European Directive on In Vitro...


Jun 01, 2016, 09:15 ET Luminex Corporation Receives CE-IVD Mark for ARIES Flu A/B & RSV Assay

 Luminex Corporation (NASDAQ: LMNX) today announced that it has received CE-IVD  status under the European Directive on In Vitro...


Jun 01, 2016, 09:15 ET Luminex Corporation erhält CE-IVD-Kennzeichnung für das ARIES Flu A/B & RSV Assay

 Luminex Corporation (NASDAQ: LMNX) gab heute bekannt, dass man den CE-IVD-Satus für das ARIES® Flu A/B & RSV Assay...


May 26, 2016, 16:05 ET Luminex Corporation To Present At Jefferies 2016 Healthcare Conference

Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the Jefferies 2016 Healthcare Conference to be held June 7-10,...


May 23, 2016, 06:00 ET Luminex Corporation and Nanosphere, Inc. Provide Update on Acquisition Agreement

 Luminex Corporation (NASDAQ: LMNX) and Nanosphere, Inc. (NASDAQ: NSPH) announced today that they have entered into an amendment to the...


May 16, 2016, 16:05 ET Luminex to Highlight Latest Additions to Product Portfolio at the 2016 Clinical Virology Symposium

Luminex Corporation (NASDAQ: LMNX) today announced it will highlight the latest additions to its product portfolio at the 32nd Annual Clinical...


May 16, 2016, 06:00 ET Luminex Corporation Signs Definitive Agreement to Acquire Nanosphere, Inc.

 Luminex Corporation (NASDAQ: LMNX) and Nanosphere, Inc. (NASDAQ: NSPH) today announced that the companies have entered into a definitive...


May 02, 2016, 16:05 ET Luminex Corporation Reports First Quarter 2016 Results

 Luminex Corporation (NASDAQ:LMNX) today announced financial results for the first quarter ended March 31, 2016.  Financial and operating...


Apr 28, 2016, 08:30 ET Luminex Corporation To Present At Investment Conferences In May

 Luminex Corporation (NASDAQ: LMNX) announced today that management will present at two upcoming investment conferences in May: - The...


Apr 14, 2016, 08:30 ET Luminex Corporation Receives FDA Clearance and CE Mark for SYNCT Software

 Luminex Corporation (NASDAQ: LMNX) today announced that its SYNCT™ Software has received both U.S. Food and Drug Administration (FDA)...


Apr 11, 2016, 16:05 ET Luminex Corporation First Quarter Earnings Release Scheduled for May 2, 2016

Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the first quarter ended March 31, 2016 on Monday, May 2,...


Apr 07, 2016, 07:00 ET Luminex Corporation to Showcase CE-IVD Marked ARIES System, Revolutionary Software, and Assays at ECCMID Annual Meeting

 Luminex Corporation (NASDAQ: LMNX) today announced that it will showcase its recently CE-IVD marked, sample to answer ARIES® molecular...